首页> 外文OA文献 >The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab

【2h】

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab

机译：用Vedolizuab处理的炎症性肠病患者患血型流感，肺炎球菌和乙型肝炎疫苗的免疫原性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jill E Harrington; Rachel E Hamilton; Lisa Ganley-Leal; Francis A Farraye; Sharmeel K Wasan;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study [J] . Launay Odile, Abitbol Vered, Krivine Anne, Journal of Crohn’s & colitis . 2015,第12期

机译：免疫调节剂和/或生物制剂治疗或未治疗的炎症性肠病患者的流感疫苗的免疫原性和安全性：一项为期两年的前瞻性研究
2. Immunogenicity is not the driving force of treatment failure in vedolizumab‐treated inflammatory bowel disease patients [J] . Van den Berghe Nathalie, Verstockt Bram, Tops Sophie, Journal of gastroenterology and hepatology . 2019,第7期

机译：免疫原性不是Vedolizuab治疗的炎症肠病患者治疗失败的驱动力
3. Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Pediatric Patients with Inflammatory Bowel Disease [J] . Banaszkiewicz Aleksandra, Targonska Brygida, Kowalska-Duplaga Kinga, Inflammatory bowel diseases . 2015,第7期

机译：小儿炎性肠病患者的13价肺炎球菌结合疫苗的免疫原性
4. Inflammatory bowel disease coexistent with viral hepatitis and HIV [C] . E. A. KOUROUMALI Falk Symposium . 2008

机译：炎症性肠病与病毒性肝炎和艾滋病毒共存
5. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. [D] . DeBruyn, Jennifer Carole Cheung. 2010

机译：炎性肠病患儿接种流感疫苗的免疫原性和安全性。
6. Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy [O] . Shimpei Shirai, Megumi Hara, Yasuhisa Sakata, -1

机译：接受免疫抑制治疗的炎症性肠病患者四价流感疫苗的免疫原性
7. P478 Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients [O] . N Van den Berghe, B Verstockt, S Tops, 2019

机译：P478免疫原性不是VEDOLIZUAB治疗的炎症肠病患者治疗失败的驱动力

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab

著录项

引文网络

相似文献

相关主题

期刊订阅